Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Acid-base fractions separated from Streblus asper leaf ethanolic extract exhibited antibacterial, antioxidant, anti-acetylcholinesterase, and neuroprotective activities

Authors: Anchalee Prasansuklab, Atsadang Theerasri, Matthew Payne, Alison T. Ung, Tewin Tencomnao

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Streblus asper is a well-known plant native to Southeast Asia. Different parts of the plant have been traditionally used for various medicinal purposes. However, there is very little scientific evidence reporting its therapeutic benefits for potential treatment of Alzheimer’s disease (AD). The study aimed to evaluate antibacterial, antioxidant, acetylcholinesterase (AChE) inhibition, and neuroprotective properties of S. asper leaf extracts with the primary objective of enhancing therapeutic applications and facilitating activity-guided isolation of the active chemical constituents.

Methods

The leaves of S. asper were extracted in ethanol and subsequently fractionated into neutral, acid and base fractions. The phytochemical constituents of each fraction were analyzed using GC-MS. The antibacterial activity was evaluated using a broth microdilution method. The antioxidant activity was determined using DPPH and ABTS radical scavenging assays. The neuroprotective activity against glutamate-induced toxicity was tested on hippocampal neuronal HT22 cell line by evaluating the cell viability using MTT assay. The AChE inhibitory activity was screened by thin-layer chromatography (TLC) bioautographic method.

Results

The partition of the S. asper ethanolic leaf extract yielded the highest mass of phytochemical constitutions in the neutral fraction and the lowest in the basic fraction. Amongst the three fractions, the acidic fraction showed the strongest antibacterial activity against gram-positive bacteria. The antioxidant activities of three fractions were found in the order of acidic > basic > neutral, whereas the decreasing order of neuroprotective activity was neutral > basic > acidic. TLC bioautography revealed one component in the neutral fraction exhibited anti-AChE activity. While in the acid fraction, two components showed inhibitory activity against AChE. GC-MS analysis of three fractions showed the presence of major phytochemical constituents including terpenoids, steroids, phenolics, fatty acids, and lipidic plant hormone.

Conclusions

Our findings have demonstrated the therapeutic potential of three fractions extracted from S. asper leaves as a promising natural source for neuroprotective agents with additional actions of antibacterials and antioxidants, along with AChE inhibitors that will benefit in the development of new natural compounds in therapies against AD.
Literature
1.
Ubel PA, Abernethy AP, Zafar SY. Full disclosure--out-of-pocket costs as side effects. N Engl J Med. 2013;369(16):1484–6.CrossRefPubMed
2.
Wang Z, Liu X, Ho RL, Lam CW, Chow MS. Precision or personalized medicine for Cancer chemotherapy: is there a role for herbal medicine. Molecules. 2016;21(7)
3.
Augustine NR, Madhavan G, Nass SJ (Eds). Committee on Ensuring Patient Access to Affordable Drug Therapies; Board on Health Care Services; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine, Making Medicines Affordable A National Imperative. Washington (DC): National Academies Press (US); 2017.
4.
Kroger E, Mouls M, Wilchesky M, Berkers M, Carmichael PH, van Marum R, et al. Adverse drug reactions reported with cholinesterase inhibitors: an analysis of 16 years of individual case safety reports from VigiBase. Ann Pharmacother 2015; 49(11):1197–1206.
5.
Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–43.CrossRefPubMed
6.
7.
8.
9.
10.
Rex JH, Talbot GH, Goldberger MJ, Eisenstein BI, Echols RM, Tomayko JF, et al. Progress in the fight against multidrug-resistant Bacteria 2005-2016: modern noninferiority trial designs enable antibiotic development in advance of epidemic bacterial resistance. Clin Infect Dis 2017; 65(1):141–146.
11.
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–61.CrossRefPubMed
12.
Owen L, Laird K. Synchronous application of antibiotics and essential oils: dual mechanisms of action as a potential solution to antibiotic resistance. Crit Rev Microbiol. 2018:1–22.
13.
Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2006;21(2):113–8.CrossRefPubMed
14.
15.
Yang WT, Zheng XW, Chen S, Shan CS, Xu QQ, Zhu JZ, et al. Chinese herbal medicine for Alzheimer's disease: clinical evidence and possible mechanism of neurogenesis. Biochem Pharmacol 2017; 141:143–155.
16.
Syad AN, Devi K. Botanics: a potential source of new therapies for Alzheimer’s disease. Botanics. 2014;4:11–6.
17.
Kumar A, Singh A, Aggarwal A. Therapeutic potentials of herbal drugs for Alzheimer’s disease - an overview. Indian J Exp Biol. 2017;55:63–73.
18.
Zangara A. The psychopharmacology of huperzine a: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav. 2003;75(3):675–86.CrossRefPubMed
19.
Mazzanti G, Di Giacomo S. Curcumin and resveratrol in the Management of Cognitive Disorders: what is the clinical evidence? Molecules. 2016;21:9.CrossRef
20.
Suk K. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids. Neurosignals. 2005;14(1–2):23–33.CrossRefPubMed
21.
Hugel HM. Brain food for Alzheimer-free ageing: focus on herbal medicines. Adv Exp Med Biol. 2015;863:95–116.CrossRefPubMed
22.
Abushouk AI, Negida A, Ahmed H, Abdel-Daim MM. Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: future applications in Parkinson's disease. Biomed Pharmacother. 2017;85:635–45.CrossRefPubMed
23.
Dey A, Bhattacharya R, Mukherjee A, Pandey DK. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions. Biotechnol Adv. 2017;35(2):178–216.CrossRefPubMed
24.
25.
Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA. Pharmacotherapeutic targets in Alzheimer's disease. J Cell Mol Med. 2009;13(1):61–86.CrossRefPubMed
26.
Wenk GL. Neuropathologic changes in Alzheimer's disease: potential targets for treatment. J Clin Psychiatry. 2006;67(Suppl 3):3–7.PubMed
27.
28.
29.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, et al. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of technology appraisal no. 111): a systematic review and economic model. Health Technol Assess. 2012;16(21):1–470.CrossRefPubMedPubMedCentral
30.
Cacabelos R. Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years? Expert Opin Drug Discov. 2018;13(6):523–38.CrossRefPubMed
31.
Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des. 2010;16(25):2766–78.CrossRefPubMed
32.
Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2010;2(1):1.CrossRefPubMedPubMedCentral
33.
Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxidative Med Cell Longev. 2013;2013:316523.
34.
Bibi F, Yasir M, Sohrab SS, Azhar EI, Al-Qahtani MH, Abuzenadah AM, et al. Link between chronic bacterial inflammation and Alzheimer disease. CNS Neurol Disord Drug Targets 2014; 13(7):1140–1147.
35.
Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, et al. Microbes and Alzheimer's disease. J Alzheimers Dis 2016; 51(4):979–984.
36.
Miklossy J, McGeer PL. Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation. Aging (Albany NY). 2016;8(4):575–88.CrossRef
37.
Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010; 5(3):e9505.
38.
Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 2016; 8(340):340ra372.
39.
Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep 2017; 7:41802.
40.
Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1DeltaE9 murine model of Alzheimer's disease. Sci Rep 2017; 7(1):10411.
41.
Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, et al. 16S rRNA next generation sequencing analysis shows Bacteria in Alzheimer's post-mortem brain. Front Aging Neurosci 2017; 9:195.
42.
Allen HB. Alzheimer's disease: assessing the role of spirochetes, biofilms, the immune system, and amyloid-beta with regard to potential treatment and prevention. J Alzheimers Dis. 2016;53(4):1271–6.CrossRefPubMedPubMedCentral
43.
Hefendehl JK, LeDue J, Ko RW, Mahler J, Murphy TH, MacVicar BA. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Abeta plaques by iGluSnFR two-photon imaging. Nat Commun. 2016;7:13441.CrossRefPubMedPubMedCentral
44.
Rastogi S, Kulshreshtha DK, Rawat AK. Streblus asper Lour. (Shakhotaka): a review of its chemical, pharmacological and Ethnomedicinal properties. Evid Based Complement Alternat Med. 2006;3(2):217–22.CrossRefPubMedPubMedCentral
45.
Verma NK, Singh SP, Singh AP, Singh R, Rai PK, Tripathi AK. A brief study on Strebulus asper L.-a review. RJP. 2015;1(2):65–71.
46.
Luanchoy S, Tiangkul S, Wongkrajang Y, Temsiririrkkul R, Peungvicha P, Nakornchai S. Antioxidant activity of a Thai traditional formula for longevity. Mahidol J Pharm Sci. 2014;41:1–5.
47.
Ren Y, Chen W-L, Lantvit DD, Sass EJ, Shriwas P, Ninh TN, et al. Cardiac glycoside constituents of Streblus asper with potential antineoplastic activity. J Nat Prod 2016; 80(3):648–658.
48.
Wongkham S, Laupattarakasaem P, Pienthaweechai K, Areejitranusorn P, Wongkham C, Techanitiswad T. Antimicrobial activity of Streblus asper leaf extract. Phytother Res. 2001;15(2):119–21.CrossRefPubMed
49.
Das MK, Beuria MK. Anti-malarial property of an extract of the plant Streblus asper in murine malaria. Trans R Soc Trop Med Hyg. 1991;85(1):40–1.CrossRefPubMed
50.
Chatterjee RK, Fatma N, Murthy PK, Sinha P, Kulshrestha DK, Dhawan BN. Macrofilaricidal activity of the stembark of Streblus asper and its major active constituents. Drug Dev Res. 1992;26(1):67–78.CrossRef
51.
Sripanidkulchai B, Junlatat J, Wara-aswapati N, Hormdee D. Anti-inflammatory effect of Streblus asper leaf extract in rats and its modulation on inflammation-associated genes expression in RAW 264.7 macrophage cells. J Ethnopharmacol. 2009;124(3):566–70.CrossRefPubMed
52.
Li J, Huang Y, Guan XL, Li J, Deng SP, Wu Q, et al. Anti-hepatitis B virus constituents from the stem bark of Streblus asper. Phytochemistry 2012; 82:100–109.
53.
Singsai K, Akaravichien T, Kukongviriyapan V, Sattayasai J. Protective effects of Streblus asper leaf extract on H2O2-induced ROS in SK-N-SH cells and MPTP-induced Parkinson’s disease-like symptoms in C57BL/6 mouse. Evid Based Complement Alternat Med. 2015;2015:970354–9.
54.
Prasansuklab A, Meemon K, Sobhon P, Tencomnao T. Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of Caenorhabditis elegans. BMC Complement Altern Med. 2017;17(1):551.CrossRefPubMedPubMedCentral
55.
Iriyama K, Ogura N. Takamiya a. A simple method for extraction and partial purification of chlorophyll from plant material, using dioxane. J Biochem. 1974;76(4):901–4.PubMed
56.
Mungkornasawakul P, Pyne SG, Jatisatienr A, Supyen D, Lie W, Ung AT, et al. Stemocurtisine, the first pyrido[1,2-a]azapine Stemona alkaloid. J Nat Prod 2003; 66(7):980–982.
57.
Marston A, Kissling J, Hostettmann K. A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants. Phytochem Anal. 2002;13(1):51–4.CrossRefPubMed
58.
Taweechaisupapong S, Wongkham S, Chareonsuk S, Suparee S, Srilalai P, Chaiyarak S. Selective activity of Streblus asper on Mutans streptococci. J Ethnopharmacol. 2000;70(1):73–9.CrossRefPubMed
59.
Taweechaisupapong S, Singhara S, Choopan T. Effect of Streblus asper leaf extract on selected anaerobic Bacteria. In: ISHS Acta Horticulturae 680: III WOCMAP congress on medicinal and aromatic plants, Vol. 6. Traditional medicine and nutraceuticals; 2005. p. 177–81.
60.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28(3):603–661.
61.
Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 2005;579(23):5157–62.CrossRefPubMed
62.
Asthana RK, Srivastava A, Kayastha AM, Nath G, Singh SP. Antibacterial potential of γ-linolenic acid from Fischerella sp. colonizing neem tree bark. World J Microbiol Biotechnol. 2006;22(5):443–8.CrossRef
63.
Huang CB, George B, Ebersole JL. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol. 2010;55(8):555–60.CrossRefPubMedPubMedCentral
64.
Desbois AP, Lawlor KC. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Mar Drugs. 2013;11(11):4544–57.CrossRefPubMedPubMedCentral
65.
Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta. 2000;1502(1):139–44.CrossRefPubMed
66.
Gadidasu K, Reddy ARN, Umate P, Reddy YN. Antioxidant and anti-diabetic activities from leaf extracts of Streblus asper Lour. Biotechnol Ind J. 2009;3(4):231–5.
67.
Ibrahim NM, Mat I, Lim V, Ahmad R. Antioxidant activity and phenolic content of Streblus asper leaves from various drying methods. Antioxidants (Basel). 2013;2(3):156–66.CrossRef
68.
Kumar RS, Kar B, Dolai N, Bala A, Haldar PK. Evaluation of antihyperglycemic and antioxidant properties of Streblus asper Lour against streptozotocin–induced diabetes in rats. Asian Pac J Trop Dis. 2012;2(2):139–43.CrossRef
69.
Kumar RB, Kar B, Dolai N, Karmakar I, Haldar S, Bhattacharya S, et al. Antitumor activity and antioxidant role of Streblus asper bark against Ehrlich ascites carcinoma in Swiss albino mice. J Exp Ther Oncol 2013; 10(3):197–202.
70.
Kumar RB, Kar B, Dolai N, Karmakar I, Bhattacharya S, Haldar PK. Antitumor activity and antioxidant status of Streblus asper bark against Dalton's ascitic lymphoma in mice. Interdiscip Toxicol. 2015;8(3):125–30.CrossRefPubMedPubMedCentral
71.
Lachman J, Šulc M, Schilla M. Comparison of the total antioxidant status of bohemian wines during the wine-making process. Food Chem. 2007;103(3):802–7.CrossRef
72.
Floegel A, Kim D-O, Chung S-J, Koo SI, Chun OK. Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods. J Food Compost Anal. 2011;24(7):1043–8.CrossRef
73.
Craig LA, Hong NS, McDonald RJ. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev. 2011;35(6):1397–409.CrossRefPubMed
74.
Tan S, Schubert D, Maher P. Oxytosis: a novel form of programmed cell death. Curr Top Med Chem. 2001;1(6):497–506.CrossRefPubMed
75.
Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007;51(6–7):333–55.CrossRefPubMedPubMedCentral
76.
Kritis AA, Stamoula EG, Paniskaki KA, Vavilis TD. Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci. 2015;9:91.CrossRefPubMedPubMedCentral
Metadata
Title
Acid-base fractions separated from Streblus asper leaf ethanolic extract exhibited antibacterial, antioxidant, anti-acetylcholinesterase, and neuroprotective activities
Authors
Anchalee Prasansuklab
Atsadang Theerasri
Matthew Payne
Alison T. Ung
Tewin Tencomnao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2288-4

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Anti-apoptotic potential of several antidiabetic medicinal plants of the eastern James Bay Cree pharmacopeia in cultured kidney cells

Research article

Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro

Research article

Anti-stress effects of human placenta extract: possible involvement of the oxidative stress system in rats

Correction

Correction to: GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia

Research article

Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells

Research article

Shuang-Huang-Lian prevents basophilic granulocyte activation to suppress Th2 immunity